amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet
- RxCUI
- 562508
- RxNorm name
- amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet
- Display name
- amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet
- Full name
- amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | 704e99b1-c14a-40bf-adbd-c2794fa92c72 | 2026-09-10 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | a26f2ceb-bb9b-4813-9691-634338186860 | 2026-08-31 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | 69e45bc0-de57-4603-a9eb-335988dfe0bf | 2026-08-29 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | e5b0770d-1301-498e-a4ed-41874d7bf225 | 2026-08-27 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 7526a33a-18d6-36ca-e053-2a91aa0ab9f9 | 2026-08-26 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | c88b2b50-c664-43b3-9c37-f134a329dc21 | 2026-08-14 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | fbd40fcd-bf5b-e91e-e053-6394a90a609c | 2026-08-12 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 1127a41b-14a1-4fe8-ae37-67ea5d760301 | 2026-07-16 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | aa77bab1-1c08-43bf-a943-0399646b3e1c | 2026-06-25 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceutials,Inc. | e0902485-69f0-7351-e053-2a95a90aa0d0 | 2026-06-23 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | e153a542-3a3c-48ff-84cf-970832d4e847 | 2026-06-19 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Northwind Health Company, LLC | 26e1d503-ab8b-ca85-e063-6394a90aaae3 | 2026-06-18 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Northwind Health Company, LLC | 1069b873-9bf9-cb22-e063-6394a90a4feb | 2026-06-18 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 92ff1408-512c-d68d-e053-2a95a90adfbd | 2026-06-18 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Micro Labs Limited | 0c2d1fbc-f80c-4737-a15e-9cfa6bf99769 | 2026-06-09 | Warnings, Adverse reactions | 562508 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | e08c1bee-14c8-4bd1-898c-1874251dadf8 | 2026-06-01 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Bryant Ranch Prepack | 263a2902-f85c-46b6-8d5b-8c99f5c4b706 | 2026-05-27 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Coupler LLC | 5102cf09-9c52-ede4-e063-6394a90abd46 | 2026-05-04 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | fabeca32-3f26-4b65-b8b6-5f0e23765ab0 | 2026-04-24 | Warnings, Adverse reactions | 562508 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Bryant Ranch Prepack | dfdde253-44b8-4074-b759-7bc40ea26cf9 | 2026-03-12 | Warnings, Adverse reactions | 562508 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f14a8008-c0ff-4628-af99-e5f07b19df71 | amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet [PSN] · amoxicillin 875 MG / clavulanate 125 MG Oral Tablet [SCD] · amoxicillin (as amoxicillin trihydrate) 875 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use AMOXICILLIN and CLAVULANATE POTASSIUM TABLETS safely and effectively. See full prescribing information for AMOXICILLIN and CLAVULANATE POTASSIUM TABLETS. AMOXICILLIN and CLAVULANATE POTASSIUM tablets for oral use Initial U.S. Approval: 1984 | 20230906 |
| f636413f-82e5-446f-94cc-b4841bdedb33 | amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet [PSN] · amoxicillin 875 MG / clavulanate 125 MG Oral Tablet [SCD] · amoxicillin (as amoxicillin trihydrate) 875 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM safely and effectively. See full prescribing information for AMOXICILLIN AND CLAVULANATE POTASSIUM. AMOXICILLIN and CLAVULANATE POTASSIUM tablets for oral use Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium and other antibacterial drugs, amoxicillin and clavulanate potassium should be used only to trea | 20220401 |
| f1e72f44-561a-4905-ab29-15ef83eac928 | amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet [PSN] · amoxicillin 875 MG / clavulanate 125 MG Oral Tablet [SCD] · amoxicillin (as amoxicillin trihydrate) 875 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet [SY] | 3 | 1 | Amoxicillin and Clavulanate Potassium Tablets, USP | 20100604 |